Objective: Patients with end-stage renal disease need vascular access to ensure sufficient blood flow during hemodialysis (HD). Patients who are poor candidates for arteriovenous access creation require long-term catheter placement. Problems such as dialysate recirculation, thrombosis, catheter-related infections, and malfunction can occur with HD catheters. Different tip designs (step, split, and symmetrical) have been developed to ameliorate the catheter-related problems. The aim of the study was to compare the efficacy and safety of split-tip, step-tip, and symmetrical-tip HD catheters.
include thrombosis, catheter-related infections, and malfunction. 5 To minimize those problems, different designs have recently been developed for clinical use. The catheters differ mainly in material, lumen diameter, tip, and side-hole designs. 6 Tip design is believed to improve catheter survival and to affect the recirculation percentage and complication rates; thus, commonly used long-term catheters have a step-tip (PermCath; Sherwood Medical, St. Louis, Mo), split-tip (Ash Split; Medcomp, Harleysville, Pa), 7 or Palindrome symmetrical-tip (Covidien, Mansfield, Mass) design (Fig 1) . Currently, the performance of any one type of catheter has not been systematically proven to be superior to that of the other types. Therefore, we performed a meta-analysis of available randomized controlled trials or relevant studies to compare the efficacy of split-, step-, and symmetricaltip HD catheters, thereby testing the hypothesis that advanced tip designs (split-or symmetrical-tip) can improve overall catheter survival, perform better in hemodynamic parameters, and reduce complications rate.
METHODS

Inclusion criteria.
Peer-reviewed randomized controlled trials and prospective and retrospective studies comparing step-, split-, or symmetrical-tip catheters in patients undergoing HD were included. The studies were also required to clearly report the inclusion and exclusion criteria for patients; HD catheters used; and definitions and methods of evaluation of catheter survival rates, effective blood flow rates, recirculation rates, and complications. We excluded studies that met at least one of the following criteria: inclusion of pediatric patients (<18 years old) and patient cohorts reported in duplicate.
Search strategy and study selection. Relevant studies published before November 2017 were identified from the databases PubMed, Embase, Scopus, and Cochrane Library. The following medical subject headings were used: (end-stage renal diseases OR renal failure OR chronic kidney diseases) AND (renal dialysis OR hemodialysis OR renal replacement therapy), ( Palindrome) . The "related articles" option in PubMed was used to broaden the search, and all abstracts, studies, and citations thus retrieved were reviewed. Finally, unpublished studies were collected from the ClinicalTrials.gov registry (http://clinicaltrials.gov/). No language restrictions were applied. The systematic review described herein has been accepted by PROSPERO (CRD42017065257).
Data extraction. Baseline and outcome data were independently retrieved by two reviewers (X.C.L. and K.W.T.). Furthermore, data regarding study designs, study population characteristics, inclusion and exclusion criteria, HD catheters used, effective blood flow rates, recirculation rates, catheter survival time, and catheterrelated complications were extracted. Decisions recorded individually by the reviewers were compared, and disagreements were resolved by a third reviewer (Y.F.L.).
Appraisal of methodologic quality. Two reviewers (X.C.L. and K.W.T.) independently assessed the methodologic quality of each study by using the risk of bias method recommended by the Cochrane Collaboration. 8 Several domains were assessed, including the adequacy of randomization, allocation concealment, outcome assessor blinding to patient information, follow-up duration, information provided to participants regarding study withdrawal, whether intention-to-treat analysis was performed, and freedom from other biases.
Outcomes. The primary outcomes were the catheter survival time and incidence of functioning catheters at 1 month, 6 months, and 12 months during catheter use. Discontinuation of catheter was censored for noncatheter-related removal (eg, maturation of vascular access, transfer to peritoneal dialysis, or recovery of renal function), so that catheters functioning within this time interval were known for all patients. The secondary outcomes were delivered blood flow rates, blood recirculation rates, and catheter-related complications.
Statistical analyses. Data were entered into and analyzed using Review Manager, version 5.3 (The Cochrane Collaboration, Oxford, England). The metaanalysis was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. 9 Standard deviations were estimated using the provided confidence interval (CI) limits or the standard errors. Dichotomous outcomes were analyzed using risk ratios (RRs) as the summary statistics. The effect sizes of continuous outcomes were reported as the weighted mean difference (WMD). The precision of the effect sizes was reported as 95% CIs. A pooled estimate of the RRs and WMDs was computed using the DerSimonian and Laird random-effects models. 10 A statistically significant result was indicated by a P value <.05 or 95% CI not including 1 in RRs and 0 in WMD. Statistical heterogeneity and the inconsistency of the treatment effects across studies were evaluated using the Cochrane Q tests and I 2 statistics, respectively. Statistical significance was set at P < .10 for the Cochrane Q tests. Statistical heterogeneity across studies was assessed using the I 2 test, which quantifies the proportion of the total outcome variability across studies. Moreover, subgroup analyses were performed by pooling available estimates for similar subsets of patients across trials. Multiple tests were adjusted by Bonferroni adjustment when the subgroup comparisons were made using exactly the same data resources. Fig 2 illustrates the flow chart of study screening and selection. The initial screen yielded 1399 citations, of which 1367 were ineligible on the basis of the criteria used for screening titles and abstracts. The records were excluded because of inappropriate population (n ¼ 925; studies without chronic kidney disease patients undergoing HD), inappropriate intervention or study design (n ¼ 438; studies that were not controlled comparisons between catheters), and inappropriate outcome (n ¼ 4; studies without clinical outcomes). Thus, the full texts of 32 studies were retrieved. However, most of these studies were excluded from our final review because 24 studies used different interventions and were case reports with systematic reviews. Thus, eight studies were eligible for inclusion in this meta-analysis. 6, [12] [13] [14] [15] [16] [17] [18] These eight studies were published between 1999 and 2014. Four studies recruited patients using step-tip or split-tip tunneled HD catheters. 13, 15, 17, 18 Another two trials recruited patients using three types of HD catheters, namely, step-tip, split-tip, and dual-lumen catheters. 14, 16 Two trials recruited patients who received HD through step-tip and symmetrical-tip catheters. 6, 12 OptiFlow (Bard Access Systems, Salt Lake City, Utah) step-tip catheters were used in two trials, 16, 18 PermCath in two studies, 13, 15 Mahurkar (Medtronic, Santa Rosa, Calif) in one trial, 14 and HemoStar (Bard) and Hickman (Bard) in two trials, respectively. 6, 17 Four studies compared the outcomes of step-tip and split-tip catheter use 13, 15, 17, 18 ; two compared the outcomes of the step-tip, split-tip, and twin catheter use 14, 16 ; and the other two compared the outcomes of the symmetrical Palindrome catheters and step-tip catheter use. 6, 12 In addition, in most of the included studies, the catheter insertion site was the right internal jugular to minimize variables during comparison. Baseline characteristics of the patients in the eight studies are shown in Table I . The methodologic quality of the included studies is summarized in Table II . Five studies reported acceptable methods of randomization. 6, 12, 15, 17, 18 Outcome assessors were not blinded to the intervention in the studies because of the distinct appearance of each catheter type. Except for the study of Van Der Meersch et al, 6 all studies used per-protocol analysis. The number of patients lost to follow-up was acceptable (<20%) in all studies except for the study of Trerotola et al. 17 If the catheters were removed during the study period, the reasons for catheter removal were clearly delineated. The study by Mankus et al 14 was categorized as high risk for selection bias because only the data from a single dialysis session were reported without stating how the selection was performed. Other biases included the lack of a standardized catheter insertion process, with guidance under two different imaging modalities for two different types of catheters, 14 and a mixed level of skills in a large group of interventionalists.
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Catheter survival time
Step-tip vs split-tip. Five studies compared catheter survival in patients using different types of catheters by plotting survival curves during the study period. 6, 12, 13, 15, 18 Catheter survival time is generally defined as the time from the insertion of the catheter to the exchange or removal of the catheter due to dysfunction. The major indications for catheter removal for all studies were thrombosis and infection. In addition, catheter survival curves were constructed with censored end points, such as recovery, conversion to AV fistula or peritoneal transplantation, transplantation, and death. O'Dwyer et al 15 reported significantly better catheter survival outcome for step-tip catheters than for split-tip catheters (P ¼ .024). In contrast, Trerotola et al 18 reported a significant survival benefit instead for split-tip compared with step-tip catheters (P ¼ .022). However, Keeling et al 13 reported no statistical difference (P ¼ .498) in catheter survival curves for step-and split-tip catheters.
Step-tip vs symmetrical-tip. Two trials compared survival outcomes between patients using step-tip catheters and those using symmetrical-tip (Palindrome) catheters. 6, 12 Van Der Meersch et al 6 reported no significant difference in the survival between the step-tip and symmetrical-tip catheter groups, although the survival curves showed higher overall survival in the step-tip catheter group (P ¼ .14). In contrast, Hwang et al 12 revealed that patients with symmetrical-tip catheters have significantly better survival outcomes than patients with step-tip catheters in comparing the time from insertion to the first catheter dysfunction (P ¼ .008).
Incidence of functioning catheters
Step-tip vs split-tip. The incidences of functioning catheters were defined as the number of functioning catheters recorded at the respective time points, which ranged from 1 month to 24 months among all included studies, over the total number of catheters inserted in each group. Comparable time points were used to facilitate meta-analysis. For step-tip vs split-tip catheter groups, the incidences of functioning catheters at 8 All studies have detection bias because blinding of assessor and operator was not feasible in the study protocols. 1 month, 6 months, and 12 months were selected for comparison. 13, 15, 18 Because Trerotolo et al 18 used 6 months as the only end point for survival rate assessment, this study was included in the comparison of outcomes at 6 months.
At 1 month after the insertion of catheters, neither patient group in the step-tip or split-tip comparison exhibited a significantly higher incidence of functioning catheters (RR, 1.05; 95% CI, 0.94-1.19). However, at 6 months after catheter insertion, the group using step-tip catheters exhibited significantly higher incidence of functioning catheters than did the group using split-tip catheters (RR, 1.22; 95% CI, 1.02-1.46). Although the step-tip catheter group appeared to have a higher incidence of functioning catheters than the split-tip catheter group at the 12-month time point, the difference was not statistically significant (RR, 1.26; 95% CI, 0.94-1.68; Fig 3) .
Step-tip vs symmetrical-tip. Hwang et al 12 reported
that the incidence of functioning catheters of the symmetrical-tip catheter group (86.4% and 78.9% at 1 month and 2 months, respectively) was significantly higher than that of the step-tip catheter group (61.7% and 54.4% at 1 month and 2 months, respectively; P < .01).
Delivered blood flow
All eight included studies compared delivered blood flow rates between step-tip and advanced-tip catheters. 6, [12] [13] [14] [15] [16] [17] [18] Blood flow rate was determined using the following formula: total volume (in liters) processed divided by time on dialysis. Because different studies reported different time points for delivered blood flow rate measurement, only the studies reporting mean blood flow rate measurements throughout the course of catheter use were compared. 6, [12] [13] [14] [15] [16] Furthermore, if multiple time points of delivered blood flow rate measurement were reported, the delivered blood flow rates during the initial HD session were used for comparison because the relevant data were reported in all the compared studies. For studies that provided more than one pump speed setting, 12, 17, 18 the maximum flow settings were used in the meta-analysis for comparison. The subgroup analysis of step-tip catheters vs split-tip catheters in these studies [13] [14] [15] [16] [17] [18] did not reveal significant differences in the effective blood flow rate between the two catheter types (WMD, À1.21 mL/min; 95% CI, À31.12 to 28.69). Similarly, no significant difference was observed between the step-tip and symmetrical-tip catheters (WMD, À12.22 mL/min; 95% CI, À45.83 to 21.40). The overall effect estimate showed no statistical difference between the conventional (step-tip) and advanced (split-tip or symmetrical-tip) catheters in terms of delivered blood flow (WMD, À5.37 mL/min; 95% CI, À23.75 to 13.02; Fig 4) .
Blood recirculation rate
Step-tip vs split-tip. Three trials compared blood recirculation rates between the step-tip and split-tip catheters.
14,17, 18 Mankus et al 14 performed recirculation tests on only a few split-tip catheters, with a majority of them revealing no recirculation. Thus, only the two studies by Trerotola et al, 17, 18 which reported recirculation rates in both catheter groups, were included in the meta-analysis for comparison. Significantly higher blood recirculation rates were observed for step-tip catheters (WMD, 4.57 mL/min; 95% CI, 3.31 to 5.84; Fig 5) ; thus, step-tip catheters have inferior outcomes compared with splittip catheters in this aspect.
Step-tip vs symmetrical-tip. Only one trial measured the blood recirculation rate between step-tip and symmetrical-tip catheters.
12 Very low recirculation rates were reported in both types of catheters, with a tendency toward lower recirculation in the step-tip catheters than in the symmetrical-tip catheters at a high pump speed (1.0% vs 3.7%, P ¼ 0.09). However, the number of patients was insufficient to confirm this finding.
Catheter-related infections
Step-tip vs split-tip. Three studies compared catheterrelated infections between patients using step-tip catheters and those using split-tip catheters for HD. 13, 15, 18 Although there is a favorable outcome toward split-tip catheters compared with step-tip catheters, catheterrelated infections in the two groups did not differ significantly (RR, 1.45; 95% CI, 0.96-2.18; Fig 6) .
Step-tip vs symmetrical-tip. Two other trials compared catheter-related infections between patients using step-tip catheters and those using symmetrical-tip catheters. 6, 12 In general, both studies reported very low incidence rates of infection in the two patient groups. Furthermore, no significant difference was observed in the risk of infection between the two groups (RR, 1.24; 95% CI, 0.04-35.02; Fig 6) . The overall effect estimate revealed no significant differences between the step-tip catheters, split-tip, and symmetrical-tip catheters in terms of catheter-related infections (RR, 1.18; 95% CI, 0.63-2.22; Fig 6) .
Catheter thrombosis
Step-tip vs split-tip. Two studies compared the incidence of thrombosis requiring thrombolytic treatments in patients using step-tip catheters and those using split-tip catheters. 13, 18 Thrombosis-related catheter malfunction events were recorded in both studies. Only the results of these studies were included in the current meta-analysis because insufficient data were reported in the other studies comparing step-tip and split-tip catheters. [14] [15] [16] [17] Nevertheless, the catheter-related thrombosis rate did not differ significantly between the two patient groups (RR, 1.69; 95% CI, 0.69-4.15; Fig 7) .
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Test for subgroup differences: Chi² = 0.23, df = 1 (P = 0.63), I² = 0% Step-tip vs symmetrical-tip. Only one study compared the thrombosis rates between patients using step-tip catheters and those using symmetrical-tip catheters. 6 This study recorded events of catheter dysfunction due to thrombosis in each group, revealing that 11 and 9 patients in the symmetrical-tip (7.3%) and step-tip (6.0%) catheter groups, respectively (P ¼ .8), experienced thrombosis. In this context, urokinase use was significantly lower in the symmetrical-tip catheter group than in the step-tip catheter group in terms of the number of urokinase infusions per 1000 catheter-days (17 vs 35, respectively; P < .001). Furthermore, a higher number of patients using symmetrical-tip catheters did not require urokinase infusions compared with those using step-tip catheters (88 vs 68; P ¼ .03). However, in terms of thrombosis incidence, the overall effect estimate revealed no significant difference between the patients using step-tip catheters and those using advanced (splittip or symmetrical-tip) catheters (RR, 1.29; 95% CI, 0.64-2.59; Fig 7) .
DISCUSSION
The main implication of this study is that no significant difference was observed in the delivered blood flow rate (P ¼ .12), incidence of catheter-related infections (P ¼ .61), or incidence of catheter-related thrombosis (P ¼ .47) between patients using step-tip catheters and those using advanced (both split-tip and symmetrical-tip) catheters. Furthermore, the outcomes of catheter survival time were disparate among studies. Moreover, 18.2%
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M-H, Random, 95% CI the incidence of functioning catheters at 1 month, 6 months, and 12 months revealed better outcome for step-tip catheter use over split-tip catheter use, although the differences were significant only at 6 months (P ¼ .03). However, a comparison of the blood recirculation rates between step-tip and split-tip catheters revealed significantly lower blood recirculation rates for the step-tip catheters. Catheter survival, rheologic properties such as blood flow and recirculation rates, and catheter-related complications have been major subjects of many studies evaluating different tip designs of HD catheters. Nevertheless, such studies have shown conflicting results and often failed to provide definite recommendations for selecting the appropriate catheter design. Our analysis revealed that although newer tip designs claim to improve catheter survival, split-tip catheters do not provide any significant survival benefit over step-tip catheters with time. Catheter survival can possibly be affected by other contributing factors, such as suboptimal tip positioning, 19 complications during insertion such as tunnel bleeding, 20, 21 and susceptibility to catheter dislodgment. 18 In our metaanalysis, we observed a discrepancy between the results of Van Der Meersch et al 6 and Hwang et al 12 when
comparing catheter survival between step-tip and symmetrical-tip catheters. The disparity could be explained by differences in center-related practices of handling catheter dysfunction, 6 but additional large-scale, prospective randomized studies are required to provide a definite recommendation.
From our results, catheter design had no potential benefit in terms of the delivered blood flow rate. However, almost all HD catheters have average flow rates >300 mL/min, the minimum flow rate acceptable according to the Dialysis Outcomes Quality Initiative vascular access guidelines. 3 A prospective cohort study by Petridis et al, 22 which compared split-tip and shotgun-tip catheters, reported that tip design did not affect long-term blood flow during dialysis. These results support our main finding. In our results, the blood recirculation rates were significantly higher in the step-tip catheters than in the split-tip catheters. The observed difference could be due to the venous lumen of the split-tip catheter extending substantially beyond the arterial lumen compared with the conventional step-tip catheter. 17 Although the recirculation rates were probably not clinically significant in relation to the average flow rates used in dialysis, any probable advantage of step-tip catheters in providing an effective blood flow rate may be offset by the higher recirculation rates in our analysis. Nevertheless, after reversing the arterial and venous blood line in 11 patients with poor inflow, Hwang et al 12 reported that the recirculation rates increased significantly in the step-tip catheters but remained unchanged in the symmetrical-tip catheters; this finding thus suggests a potential advantage of symmetrical-tip over step-tip catheters.
Our results reveal no significant difference in the incidence of catheter-related complications, such as infection and thrombosis, among all catheter groups. The ideal HD catheter (ie, one devoid of infection and fibrin sheath formation) is currently unavailable. In terms of other complications, O'Dwyer et al 15 reported an increased incidence of spontaneous catheter dislodgment for a split-tip catheter compared with a step-tip catheter; this was caused by poorly functioning tissue ingrowth cuff and was later rectified by the manufacturer. Furthermore, they reported that the split-tip catheter was not more susceptible to minor complications than the step-tip catheter (P ¼ .48) after dislodgment was ameliorated. 15 Overall, our results reveal lower infection and thrombosis rates in patients using split-tip catheters; this thus necessitates the execution of additional, larger studies to validate this observation. Issues of procedural difficulty and time required for insertion represent another factor to be considered during catheter selection. Richard et al 16 procedure times in split-tip than in step-tip catheters (P ¼ .04), suggesting that thinner-walled catheters such as Ash Split are more prone to kinking and require more time for reducing kinking. Although all of our included studies did not mention the cost of the catheters, cost-efficacy is still a major deciding factor in catheter selection and warrants discussion. Split-tip catheters such as Ash Split cost, on average, U.S. $395 for a complete kit, and step-tip catheters such as OptiFlow and PermCath cost U.S. $160 to U.S. $280. 17, 18 Furthermore, a symmetrical-tip catheter kit costs more than U.S. $1000 on average. However, with comparable catheter survival, delivered blood flow rates, and incidence of catheter-related complications to other types of catheters, we recommend step-tip catheters because of their cost-effectiveness. Discussions of these additional factors in catheter selection can further help facilitate health care decision-making and even encourage future, high-quality studies to improve health care management. The studies included in our meta-analysis exhibited considerable heterogeneity because of various clinical factors. First, certain catheters from the same group differed among the included studies. For example, the step-tip catheters used in the included trials included OptiFlow, HemoStar, Mahurkar, and the conventional PermCath. Second, there were differences in centerrelated practices of handling catheters and catheter care and maintenance. However, the included studies have adhered to standardized and well-defined catheter care protocols, thus rendering the risks of unsafe practices low. Third, protocols for catheter dysfunction salvage were not standardized among the studies. Finally, the time points of outcome evaluation differed in some trials as discussed. Such differences among the trials can explain the observed heterogeneity. One of the strengths in this meta-analysis is a systematic manner of aggregating data of established studies to improve statistical power and to reduce error. A calculation with reference to Van Der Meersch et al 6 revealed the necessary sample size for a power of 80% to detect catheter removal for infection or thrombosis during the study period to be 190-102 in each arm; our meta-analysis has achieved a sample size well above this. Moreover, our study did not include cohort studies with only a single catheter because treatment effects were better attributed to catheter differences in studies with well-controlled comparisons. However, this study has several limitations. First, some trials had a small sample size of approximately 10 in their treatment groups.
14,17 Second, some outcomes could not be pooled for meta-analysis or were converted using an approximation protocol because of insufficient data. For example, O'Dwyer et al 15 provided only the mean blood flow rate during dialysis without the corresponding standard deviation. Third, one retrospective study was included in our analysis. 13 However, the authors have addressed the risk of any possible confounding bias and provided an optimal model to improve data quality. Fourth, because no hazard ratio was provided by the original studies, the competing risks, such as peritoneal dialysis, transplantation, and death, might affect the results for the outcome of interest in the incidence of functioning catheters. Finally, most of the included trials were short-term trials lasting 1 to 2 years. Ideally, longer studies could be performed for completely evaluating the long-term complications and survival rates associated with catheters.
CONCLUSIONS
All types of catheters were comparable in delivering adequate HD blood flow and maintaining an optimal catheter survival in addition to being similar in terms of catheter-related complications, including infection and thrombosis. Although the mechanical design of split-tip catheters could slightly improve blood recirculation rates, no potential benefits were observed in catheter survival and complication rates. None of the catheter types showed unique features that may enhance their suitability for application; hence, catheters can be selected by also considering different factors, including costs, ease of procedures, expertise of the clinician, education of the nurse and patient, and preference of the patient.
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